2 天
News-Medical.Net on MSNAlready approved drug avapritinib shows promise in treating high-grade gliomasHigh-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...
4 天
HealthDay on MSNFirefighters' brain tumors linked to flame retardant chemicalFirefighters might face a higher risk of brain cancers caused by exposure to chemicals in fire extinguishers, a new ...
Brain tumours remain the most common cause of death from childhood cancer. Paediatric high-grade gliomas (pHGG) in particular ...
A new study published in the journal of Menopause found that overall, among menopausal women, the usage and duration of ...
1 天
News-Medical.Net on MSNNew therapeutic approach shows promise for pediatric high-grade gliomasBrain tumors remain the most common cause of death from childhood cancer. Paediatric high-grade gliomas (pHGG) in particular are a mostly fatal disease group with a median survival time of less than ...
5 天
News Medical on MSNMutational Signature in Gliomas Tied to Chemical Exposure in FirefightersUsing glioma tumor samples, researchers looked for genetic mutational signatures, finding one previously associated with ...
Firefighters may face a heightened risk of developing brain cancer due to their persistent exposure to certain chemicals, a ...
5 天
News Medical on MSNFirefighters face a higher brain cancer risk associated with gene mutations caused by ...Gene mutations caused by exposure to certain chemical compounds have been linked to the development of gliomas, the most ...
Gene mutations caused by exposure to certain chemical compounds have been linked to the development of gliomas, the most common type of malignant brain tumor. New research published by Wiley online in ...
In a study published online March 10 in Cancer, authors identified gliomas with mutational signatures associated with ...
There appears to be a connection between prenatal per- and polyfluoroalkyl substance (PFAS) serum concentrations and some childhood cancers.
Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to accelerating promising treatments, has announced enrollment of the first two pa ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果